Clinical Trial

Testosterone Treatment in Men With Chronic Kidney Disease

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study in being conducted in men who have low testosterone and chronic kidney disease. The investigators will evaluate the effects of an oral testosterone preparation, JATENZO, on testosterone levels and hemoglobin (red blood cells).
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-02-18; most recent amendment 2026-04-24.
Trial Details
NCT Number NCT05249634
Lead Sponsor St. Louis University
Collaborators: Clarus Therapeutics, Inc.
Conditions Hypogonadism, Male, Kidney Disease, Chronic
Enrollment 20 participants
Start Date 2022-03-15
Primary Completion 2028-06 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-30